
Artemis Medicare Services Limited
The current stock price of Artemis Medicare Services Limited is ₹240.80, with a target price range between ₹228.76 and ₹252.84. The stock has experienced a price change of ₹4.21 (1.78%), reflecting recent market volatility.
Today's opening price was ₹237.80, while the previous close stood at ₹236.59.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Artemis Medicare Services Limited Price Chart
Artemis Medicare Services Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 237.8
- Previous Close Price: 236.59
- Change: 1.21%
- Total Traded Volume: 15
- Total Buy Quantity: 6,783
- Total Sell Quantity: 13,037
Price | Buy Qty | Sell Qty |
---|---|---|
235.05 | 200.00 | 0.00 |
235.20 | 2.00 | 0.00 |
235.30 | 200.00 | 0.00 |
236.59 | 42.00 | 0.00 |
237.00 | 15.00 | 0.00 |
237.80 | 0.00 | 130.00 |
239.90 | 0.00 | 250.00 |
240.00 | 0.00 | 1,400.00 |
240.13 | 0.00 | 5.00 |
240.70 | 0.00 | 140.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
240.59 | 16 | 240.80 | 32 |
240.47 | 1 | 240.99 | 10 |
240.46 | 11 | 241.00 | 235 |
240.41 | 10 | 241.08 | 5 |
240.35 | 10 | 241.19 | 1 |
Shareholding Patterns of Artemis Medicare Services Limited
Key Trade Statistics of Artemis Medicare Services Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | 0.96 |
Traded Value (₹ Cr.) | 2.32 |
Total Market Cap (₹ Cr.) | 3,313.46 |
Free Float Market Cap (₹ Cr.) | 768.19 |
Impact cost | 0.17 |
Quantity Traded | 89,400.00 |
Deliverable Quantity | 46,481.00 |
% of Quantity to Traded | 51.99 |
Security VaR | 19.17 |
Index VaR | N/A |
VaR Margin | 19.17 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | 12.33 |
Applicable Margin Rate | 35 |
Face Value | 1 |
Key Price Statistics of Artemis Medicare Services Limited
The 52-week high for Artemis Medicare Services Limited was ₹350.00, recorded on 19-Dec-2024. On the other hand, the 52-week low stands at ₹143.05, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹283.90, and the lower band is ₹189.27. The price band is 20%.
The stock's daily volatility stands at 2.93, while the annualized volatility is 55.98. The tick size for trading is ₹0.01.
Price Information | Details |
---|---|
52 Week High (19-Dec-2024) | 350.00 |
52 Week Low (04-Jun-2024) | 143.05 |
Upper Band | 283.90 |
Lower Band | 189.27 |
Price Band (%) | 20 |
Daily Volatility | 2.93 |
Annualised Volatility | 55.98 |
Tick Size | 0.01 |
Key Securities Statistics of Artemis Medicare Services Limited
Securities Information | Details |
---|---|
Status | Listed |
Trading Status | Active |
Date of Listing | 23-Jan-2020 |
Adjusted P/E | 44.26 |
Symbol P/E | 44.26 |
Index | NA |
Macro-Economic Sector | Healthcare |
Sector | Healthcare |
Industry | Healthcare Services |
Basic Industry | Hospital |
Security Status of Artemis Medicare Services Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Artemis Medicare Services Limited
Subject | Date |
---|---|
Updates | 17-Feb-2025 |
Copy of Newspaper Publication | 06-Feb-2025 |
Monitoring Agency Report | 05-Feb-2025 |
Investor Presentation | 05-Feb-2025 |
Press Release | 05-Feb-2025 |
Updates | 05-Feb-2025 |
Integrated Filing- Financial | 05-Feb-2025 |
Statement of deviation(s) or variation(s) under Reg. 32 | 05-Feb-2025 |
Corporate Actions of Artemis Medicare Services Limited
Face Value | Purpose | Ex-Date |
---|---|---|
1 | Dividend - Rs 0.45 Per Share | 05-Jul-2024 |
1 | Dividend - Re 0.45 Per Share | 14-Jul-2023 |
1 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share | 23-Sep-2021 |
1 | Annual General Meeting | 12-Jul-2021 |
1 | Annual General Meeting | 15-Sep-2020 |
Board Meetings of Artemis Medicare Services Limited
Financial Results of Artemis Medicare Services Limited
Company Directory of Artemis Medicare Services Limited
Web Address | Office | Address | City |
---|---|---|---|
www.artemishospitals.com | Head Office/ Corporate Office | Artemis Hospitals, Sector-51, Gurgaon, Haryana, 122001 | N/A |
www.artemishospitals.com | Registered Office | Plot No. 14, Artemis Medicare Services Limited Sectro 20, Dwaraka, West Delhi, Delhi 110075 | N/A |
Insider Trading of Artemis Medicare Services Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | Neeru Wahal | 408798 | Buy |
7(2) | Prem Narain Wahal | 756559 | Buy |
7(2) | Prem Narain Wahal | 182537 | Buy |
7(2) | Neeru Wahal | 494790 | Buy |
7(2) | Prem Narain Wahal | 182537 | Buy |
7(2) | Neeru Wahal | 494790 | Buy |
Annual Reports of Artemis Medicare Services Limited
Investor Complaints of Artemis Medicare Services Limited
Event Calendar of Artemis Medicare Services Limited
Purpose | Details |
---|---|
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2019 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
Other business matters | To consider other business matters i.e. Issue of Sweat Equity Shares |
Financial Results | Board Meeting Intimation for Consideration of Un-audited financial results (Standalone & Consolidated) for the quarter/half year ended 30th September 2020 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
Financial Results/Stock Split | To consider and approve the financial results for the period ended Jun 30, 2021 and stock split of equity shares |
Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
Financial results | Artemis Medicare Services Limited has informed the Exchange about Board Meeting to be held on 11-May-2022 to consider financial statements for the period ended March 2022 |
Financial results | Artemis Medicare Services Limited has informed the Exchange about Board Meeting to be held on 11-Aug-2022 to consider financial statements for the period ended June 2022 |
Financial results | Artemis Medicare Services Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2022 to consider financial statements for the period ended September 2022 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend, if any |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
Fund Raising | The meeting of the Board of Directors of the Company is scheduled on 05/04/2024 ,inter alia, to consider and approve the proposal for raising of funds by way of means permissible under applicable laws such as issue of equity shares/ convertible bonds/ debentures/ warrants/ preference shares/ any other equity linked securities and/ or any other securities including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combinations thereof. |
Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results | to consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2024 |
Financial Results | To consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ half year ended September 30, 2024. |
Financial Results | To consider and approve the Un-audited Financial Results (Standalone & Consolidated) for the quarter/ nine months period ended December 31, 2024. |
Share Transfers of Artemis Medicare Services Limited
Voting Results of Artemis Medicare Services Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
26-DEC-2024 | Postal Ballot | Re-appointment of Dr. Devlina Chakravarty (DIN: 07107875) as Managing Director |
26-DEC-2024 | Postal Ballot | Appointment of Mr. Vinod Rai (DIN: 00041867) as an Independent Director |
09-SEP-2024 | Postal Ballot | Appointment of Mr. Akshaykumar Narendrasinhji Chudasama (DIN: 00010630) as an Independent Director |
09-SEP-2024 | Postal Ballot | Appointment of Ms. Pallavi Shardul Shroff (DIN: 00013580) as an Independent Director |
24-JUL-2024 | AGM | TO CONSIDER AND ADOPT:nA. THE AUDITED FINANCIAL STATEMENT OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024, THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON; ANDnB. THE AUDITED CONSOLIDATED FINANCIAL STATEMENT OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024 AND REPORT OF AUDITORS THEREON. |
24-JUL-2024 | AGM | APPROVAL FOR PAYMENT OF CONSULTANCY FEES TO DR. NIRMAL KUMAR GANGULY n(DIN: 02316154), NON-EXECUTIVE DIRECTOR OF THE COMPANY |
24-JUL-2024 | AGM | RATIFICATION OF PAYMENT OF REMUNERATION TO COST AUDITOR FOR THE FINANCIAL YEAR 2024-25 |
24-JUL-2024 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MS. SHALINI KANWAR CHAND (DIN: 00015511), WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HERSELF FOR RE-APPOINTMENT |
24-JUL-2024 | AGM | TO DECLARE THE FINAL DIVIDEND OF RE. 0.45 PER EQUITY SHARE, FOR THE FINANCIAL YEAR ENDED MARCH 31, 2024 |
03-MAY-2024 | EGM | TO CONSIDER AND APPROVE ISSUANCE OF COMPULSORILY CONVERTIBLE DEBENTURES BY WAY OF A PREFERENTIAL ISSUE ON A PRIVATE PLACEMENT BASIS TO INTERNATIONAL FINANCE CORPORATION |
03-MAY-2024 | EGM | FIXATION OF TENURE OF MR. ONKAR KANWAR (DIN: 00058921) CHAIRMAN AND NON- EXECUTIVE DIRECTOR OF THE COMPANY |
03-MAY-2024 | EGM | TO CONSIDER AND APPROVE THE GRANT OF SPECIAL RIGHTS TO INTERNATIONAL FINANCE CORPORATION |
01-AUG-2023 | AGM | TO RECEIVE, CONSIDER AND ADOPT:nA. THE AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR FINANCIAL YEAR ENDED MARCH 31, 2023, THE REPORTS OF BOARD OF DIRECTORS AND AUDITORS THEREON; ANDnB. THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023 AND REPORT OF AUDITORS THEREONn |
01-AUG-2023 | AGM | APPROVAL FOR PAYMENT OF CONSUTANCY FEE TO DR. NIRMAL KUMAR GANGULY (DIN:02316154), NON-EXECUTIVE DIRECTOR OF THE COMPANY |
01-AUG-2023 | AGM | RE-APPOINTMENT OF MR. SANJIB SEN (DIN:07088442) AS AN INDEPENDENT DIRECTOR OF THE COMPANY |
01-AUG-2023 | AGM | RATIFICATION OF PAYMENT OF REMUNERATION TO COST AUDITOR FOR THE FINANCIAL YEAR 2023-24 |
01-AUG-2023 | AGM | TO APPOINT A DIRECTOR IN PLACE OF MR. NEERAJ KANWAR (DIN:00058951) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFER HIMSELF FOR RE-APPOINTMENT |
01-AUG-2023 | AGM | TO DECLARE DIVIDEND OF RE. 0.45 PER EQUITY SHARE, FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023 |
18-MAR-2023 | Postal Ballot | To approve payment of remuneration to Dr. Devlina Chakravarty (DIN: 07107875) as Managing Director of the Company for a period of 2 years w.e.f. April 01, 2023 to March 31, 2025 |
13-JUL-2022 | AGM | To receive, consider and adopt the audited financial statements (Standalone and Consolidated) of the Company for the financial year ended 31st March, 2022 and the reports of the Board of Directors and Auditors thereon. |
FAQs on Artemis Medicare Services Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.